N-ethyl-1-(3-fluorophenyl)propan-2-amine
N-ethyl-1-(3-fluorophenyl)propan-2-amine (3-FEA) is a substituted amphetamine with stimulating and empathogenic effects. It primarily acts by inhibiting the reuptake of dopamine, norepinephrine, and serotonin, leading to increased neurotransmitter activity. The substance is structurally related to other fluorinated phenethylamines and has a moderate risk profile, particularly concerning cardiovascular and neurotoxic effects.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
Designations
IUPAC: N-ethyl-1-(3-fluorophenyl)propan-2-amine
Synapedia Evidence
Effects & Pharmacology is partially translated. Some content may appear in German.
3-FEA inhibits the reuptake of dopamine, norepinephrine, and serotonin, enhancing their activity in the synaptic cleft.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Risks & Harm Reduction — Translation in progress
This section is being translated. Content is available in German.
View in German →The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.